Igarashi Y
Department of Cardiovacular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1991 Sep;66(5):647-57.
Catecholamines (CAs) had been used for the treatment of congestive heart failure (CHF). However, since continuous administration of CAs develops tolerance in hemodynamics presumably due to desensitization of beta-adrenergic receptor (beta AR)-adenylate cyclase (AC) system, beta antagonist, instead of beta agonist, has recently been employed to treat CHF, in that it may recover beta AR-AC system. In this study, the precise mechanisms of alterations in cardiac beta AM-AC system after chronic administration of beta agonist or antagonist, were investigated. The rats were treated continuously for 14 days with saline, isoproterenol (ISO), atenolol (ATENO), or denopamine (DENO), a new positive inotropic agent with beta 1 selective AR agonistic properties, which is reported to hardly cause the tolerance in clinical studies. beta AR density (Bmax) was markedly reduced by ISO and slightly increased by ATENO. Forskolin stimulated cyclase activity was reduced markedly by ISO. Total amount of the pertussis toxin substrates (inhibitory G-protein; Gi) and cholera toxin substrates (stimulatory G-protein; Gs) were not different among 4 groups. However, Gs activity measured by human platelet reconstitutive assay was reduced by ISO and DENO. These results indicate that ISO-induced desensitization in caused by the reduction in Gs and AC-catalytic activity as well as by the down-regulation of beta AR. Furthermore, it is suggested that DENO may cause slight desensitization of beta AR-AC system due to reduced Gs activity.
儿茶酚胺(CAs)曾被用于治疗充血性心力衰竭(CHF)。然而,由于持续给予CAs会在血流动力学方面产生耐受性,推测这是由于β-肾上腺素能受体(βAR)-腺苷酸环化酶(AC)系统脱敏所致,因此近来使用β拮抗剂而非β激动剂来治疗CHF,因为它可能恢复βAR-AC系统。在本研究中,对长期给予β激动剂或拮抗剂后心脏βAR-AC系统改变的精确机制进行了研究。将大鼠连续14天用生理盐水、异丙肾上腺素(ISO)、阿替洛尔(ATENO)或多巴胺(DENO,一种具有β1选择性AR激动特性的新型正性肌力药物,据报道在临床研究中几乎不会引起耐受性)进行处理。ISO使βAR密度(Bmax)显著降低,而ATENO使其略有增加。ISO使福司可林刺激的环化酶活性显著降低。4组之间百日咳毒素底物(抑制性G蛋白;Gi)和霍乱毒素底物(刺激性G蛋白;Gs)的总量没有差异。然而,通过人血小板重组试验测定的Gs活性被ISO和DENO降低。这些结果表明,ISO诱导的脱敏是由Gs和AC催化活性降低以及βAR下调所致。此外,提示DENO可能由于Gs活性降低而导致βAR-AC系统轻微脱敏。